The role of neuroinflammation in Alzheimer’s disease and evaluation of the effect of the Standardized Extract of Asparagus Officinalis Stem in mild cognitive impairment

Open Access

Issue		BIO Web Conf. Volume 187, 2025 2025 Joint Meeting of International Conference of Nutritional Fortification (ISPH-ISNPR 2025)


Article Number		02002
Number of page(s)		13
Section		Neuroscience
DOI		https://doi.org/10.1051/bioconf/202518702002
Published online		09 September 2025

GBD 2019 Dementia Forecasting Collaborators, Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 7, 105–125 (2022). https://doi.org/10.1016/S2468-2667(21)00249-8 [Google Scholar]
V.A. Parfenov, V.V. Zaharov, I.S. Preobrazhenskaja, Cognitive disorders (Remedium, Moscow, 2014) [Google Scholar]
R.C. Petersen, O. Lopez, M.J. Armstrong, T.S.D. Getchius, M. Ganguli, D. Gloss, G.S. Gronseth, D. Marson, T. Pringsheim, G.S. Day, M. Sager, J. Stevens, A. Rae-Grant, Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 90, 126–135 (2018). https://doi.org/10.1212/WNL.0000000000004826 [Google Scholar]
A.B. Lokshina, V.V. Zakharov, D.A. Grishina, Heterogeneity of the mild cognitive impairment syndrome (specialized outpatient service data analysis). Neurology, Neuropsychiatry, Psychosomatics. 13, 34–41 (2021). https://doi.org/10.14412/2074-2711-2021-3-34-41 [Google Scholar]
V.A. Parfenov, D.A. Grishina, A.B. Lokshina V.V. Grinyuk, V.V. Zakharov, K.V. Shevtsova, Mild cognitive impairment due to cerebrovascular disease and Alzheimer’s disease. Neurology, Neuropsychiatry, Psychosomatics. 17, 78–82 (2025) [Google Scholar]
V.A. Parfenov, V.V. Zakharov, A.R. Kabaeva, N.V. Vakhnina, Subjective cognitive decline as a predictor of future cognitive decline: a systematic review. Dement Neuropsychol. 14, 248–257 (2020). https://doi:10.1590/1980-57642020dn14030007 [Google Scholar]
L.S. Prichep, E.R. John, S.H. Ferris, L. Rausch, Z. Fang, R. Cancro, C. Torossian, B. Reisberg, Prediction of longitudinal cognitive decline in normal elderly with subjective complaints using electrophysiological imaging. Neurobiol Aging. 27, 471–481 (2006). https://doi:10.1016/j.neurobiolaging.2005.07.021 [Google Scholar]
Y. Lin, P.Y. Shan, W.J. Jiang, C. Sheng, L. Ma, Subjective cognitive decline: preclinical manifestation of Alzheimer’s disease. Neurol Sci. 40, 41–49 (2019). https://doi.org/10.1007/s10072-018-3620-y. [Google Scholar]
A. Rostamzadeh, L. Bohr, M. Wagner, C. Baethge, F. Jessen, Progression of Subjective Cognitive Decline to MCI or Dementia in Relation to Biomarkers for Alzheimer Disease: A Meta-analysis. Neurology. 99, 1866–1874 (2022). https://doi:10.1212/WNL.0000000000201072 [Google Scholar]
F. Jessen, R.E. Amariglio, R.F. Buckley, W.M. van der Flier, Y. Han, J.L. Molinuevo, L. Rabin, D.M. Rentz, O. Rodriguez-Gomez, A.J. Saykin, S.A.M. Sikkes, C.M. Smart, S. Wolfsgruber, M. Wagner, The characterisation of subjective cognitive decline. Lancet Neurol. 19, 271–278 (2020). https://doi:10.1016/S1474-4422(19)30368-0 [Google Scholar]
S. Wolfsgruber, A. Polcher, A. Koppara, L. Kleineidam, L. Frolich, O. Peters, M. Hull, E. Ruther, J. Wiltfang, W. Maier, J. Kornhuber, P. Lewczuk, F. Jessen, M. Wagner, Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment. J Alzheimers Dis. 58, 939–950 (2017). https://doi:10.3233/JAD-161252 [Google Scholar]
C.R. Jr Jack, D.A. Bennett, K. Blennow, M.C. Carrillo, B. Dunn, S.B. Haeberlein, D. M. Holtzman, W. Jagust, F. Jessen, J. Karlawish, E. Liu, J.L. Molinuevo, T. Montine, C. Phelps, K.P. Rankin, C.C. Rowe, P. Scheltens, E. Siemers, H.M. Snyder, R. Sperling, Contributors, NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 14, 535–562 (2018). https://doi:10.1016/j.jalz.2018.02.018 [CrossRef] [PubMed] [Google Scholar]
B. Dubois, N. Villain, G.B. Frisoni, G.D. Rabinovici, M. Sabbagh, S. Cappa, A. Bejanin, S. Bombois, S. Epelbaum, M. Teichmann, M.-O. Habert, A. Nordberg, K. Blennow, D. Galasko, Y. Stern, C.C. Rowe, S. Salloway, L.S. Schneider, J. L. Cummings, H.H. Feldman, Clinical diagnosis of Alzheimer’s disease: recommendations of the International Working Group. Lancet Neurol. 20, 484–496 (2021). https://doi:10.1016/S1474-4422(21)00066-1 [Google Scholar]
H.H. Kampinga, E.A. Craig, The Hsp70 chaperone machinery: J-proteins as drivers of functional specificity. Nat Rev Mol Cell Biol. 11, 579–592 (2010). https://doi:10.1038/nrm2941. [Google Scholar]
D.J. Selkoe, Cell biology of protein misfolding: the examples of Alzheimer’s and Parkinson’s diseases. Nat Cell Biol. 6, 10541061 (2004). https://doi:10.1038/ncb1104-1054 [Google Scholar]
S. Inoue, J. Takanari, K. Abe, A. Nagayama, Y. Ikeya, N. Kohda, Isolation and Structure Determination of a Heat Shock Protein Inducer, Asparagus-Derived ProlineContaining 3-Alkyldiketopiperazines (Asparaprolines), From a Standardized Extract of Asparagus officinalis Stem. Nat Prod Commun. 15, 1–7 (2020) [Google Scholar]
T. Sakurai, T. Ito, K. Wakame, K. Kitadate, T. Arai, J. Ogasawara, T. Kizaki, S. Sato, Y. Ishibashi, T. Fujiwara, K. Akagawa, H. Ishida, H. Ohno, Enzyme-treated Asparagus officinalis extract shows neuroprotective effects and attenuates cognitive impairment in senescence-accelerated mice. Nat Prod Commun. 9, 101–106 (2014) [Google Scholar]
T. Koda, J. Takanari, K. Kitadate, H. Imai, Enzyme-treated Asparagus Extract (ETAS) Enhances Memory in Normal Rats and Induces Neurite-outgrowth in PC12 Cells. Nat Prod Commun, 12, 1631–1633 (2017) [Google Scholar]
Y.C. Chan, C.S. Wu, T.C. Wu, Y.H. Lin, S.J. Chang, A Standardized Extract of Asparagus officinalis Stem (ETAS®) Ameliorates Cognitive Impairment, Inhibits Amyloid β Deposition via BACE-1 and Normalizes Circadian Rhythm Signaling via MT1 and MT2. Nutrients. 11, 1631 (2019). https://doi:10.3390/nu11071631 [Google Scholar]
R.C. Petersen, Mild cognitive impairment as a diagnostic entity. J Intern Med. 256, 183–194 (2004). https://doi:10.1111/j.13652796.2004.01388.x [Google Scholar]
American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders DSM-5, 5th ed. (American Psychiatric Publishing, Arlington, VA, USA, 2013) [Google Scholar]
A.J. Steven, Sample size of 12 per group rule of thumb for a pilot study. Pharmaceut. Statist. 4, 287–291 (2005) [Google Scholar]
Y. Kanda, Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 48, 452–458 (2013) [CrossRef] [PubMed] [Google Scholar]
L. Bracco, C. Piccini, L. Amaducci, Rate of progression of mental decline in Alzheimer disease: summary of European studies. Alzheimer Dis Assoc Disord. 12, 347–355 (1998). https://doi:10.1097/00002093-199812000-00016 [Google Scholar]
Y. Liu, J.T. Yu, H.F. Wang, P.R. Han, C.C. Tan, C. Wand, X.F. Meng, S.L. Risacher, A.J. Saykin L. Tan, APOE genotype and neuroimaging markers of Alzheimer’s disease: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry, 86, 127–134 (2015). https://doi:10.1136/jnnp-2014-307719 [Google Scholar]
D. L. Sultzer, C.V. Brown, M.A. Mandelkern, M.E. Mahler, M.F. Mendez, S.T. Chen, J.L. Cummings, Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer’s disease. Am J Psychiatry. 160, 341–349 (2003). https://doi:10.1176/appi.ajp.160.2.341 [Google Scholar]
S. Nakano, F. Yamashita, H. Matsuda, C. Kodama, T. Yamada, Relationship between delusions and regional cerebral blood flow in Alzheimer’s disease. Dement Geriatr Cogn Disord. 2, 16–21 (2006). https://doi:10.1159/000089215 [Google Scholar]
H. Tuokko, T. Hadjistavropoulos, J.A. Miller, B.L. Beattie, The Clock Test: a sensitive measure to differentiate normal elderly from those with Alzheimer disease. J Am Geriatr Soc. 40, 579–584 (1992). https://doi:10.1111/j.1532-5415.1992.tb02106.x [Google Scholar]
K. I. Shulman, Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry. 15, 548–561 (2000). https://doi:10.1002/1099-1166(200006)15:6<548::aid-gps242>3.0.co;2-u [Google Scholar]
I. Rouleau, D. P. Salmon, N. Butters, Longitudinal analysis of clock drawing in Alzheimer’s disease patients. Brain Cogn. 31, 17–34 (1996). https://doi:10.1006/brcg.1996.0022 [Google Scholar]
C.M. Parsey, M. Schmitter-Edgecombe, Quantitative and qualitative analyses of the clock drawing test in mild cognitive impairment and Alzheimer disease: evaluation of a modified scoring system. J Geriatr Psychiatry Neurol. 24, 108–118 (2011). https://doi:10.1177/0891988711402349 [Google Scholar]
T. Ito, K. Goto, J. Takanari, T. Miura, K. Wakame, H. Nishioka, A. Tanaka, J. Nishihira, Effects of Enzyme-Treated Asparagus Extract on Heat Shock Protein 70, Stress Indices, and Sleep in Healthy Adult Men. J Nutr Sci Vitaminol. 60, 283–290 (2014). https://doi:10.3177/jnsv.60.283 [Google Scholar]
A. Larbi, G. Pawelec, J.M. Witkowski, H. M. Scipper, E. Derhovanessian, D. Goldeck, T. Fulop, Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer’s disease. J Alzheimers Dis. 17, 91–103 (2009). https://doi:10.3233/JAD-2009-1015 [Google Scholar]
M. Pellicanò, A. Larbi, D. Goldeck, G. Colonna-Ramano, S. Buffa, M. Bulati, G. Rubino, F. Lemolo, G. Candore, C. Caruso, E. Derhovanessian, G. Pawelec, Immune profiling of Alzheimer patients. J Neuroimmunol. 242, 52–59 (2012). https://doi:10.1016/j.jneuroim.2011.11.005 [Google Scholar]
J. Magrané, R.C. Smith, K. Walsh, H.W. Querfurth, Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed beta-amyloid in neurons. J Neurosci. 24, 1700–1706 (2004). https://doi:10.1523/JNEUROSCI.433003.2004 [Google Scholar]
T. Hoshino, N. Murao, T. Namba, M. Takehara, H. Adachi, M. Katsuno, G. Sbue, T. Matsushima, T. Suzuki, T. Mizushima, Suppression of Alzheimer’s disease-related phenotypes by expression of heat shock protein 70 in mice. J Neurosci. 31, 5225–5234 (2011). https://doi:10.1523/JNEUROSCI.5478-10.2011 [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.